![](/img/cover-not-exists.png)
391 LOXO-101, a pan TRK inhibitor, for the treatment of TRK-driven cancers
Winski, S., Baer, B., Hartley, D., Rhodes, S., Wallace, R., Smith, S., Nanda, N., Kunkle, L., Lee, P., Bouhana, K.Volume:
50
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(14)70517-9
Date:
November, 2014
File:
PDF, 59 KB
english, 2014